Close

Theravance Biopharma (TBPH) Misses Q2 EPS by 1c

August 8, 2016 4:44 PM EDT

Theravance Biopharma (NASDAQ: TBPH) reported Q2 EPS of ($1.06), $0.01 worse than the analyst estimate of ($1.05).

For earnings history and earnings-related data on Theravance Biopharma (TBPH) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings